Plunkett ML - Search Results

1

Silver S, Williams E, Plunkett ML. Silver S, et al. Among authors: plunkett ml. Am Fam Physician. 2024 Feb;109(2):119-129. Am Fam Physician. 2024. PMID: 38393796

2

A clinical pathway for guardianship at Dartmouth-Hitchcock Medical Center.

Chen JJ, Blanchard MA, Finn CT, Plunkett ML, Homa K, Fournier DA, Gregoire JF, Handley MM, Stedina EA, Suresh GK, Nugent WC. Chen JJ, et al. Among authors: plunkett ml. Jt Comm J Qual Patient Saf. 2014 Sep;40(9):389-97. doi: 10.1016/s1553-7250(14)40051-5. Jt Comm J Qual Patient Saf. 2014. PMID: 25252387

3

Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth.

Doñate F, Parry GC, Shaked Y, Hensley H, Guan X, Beck I, Tel-Tsur Z, Plunkett ML, Manuia M, Shaw DE, Kerbel RS, Mazar AP. Doñate F, et al. Among authors: plunkett ml. Clin Cancer Res. 2008 Apr 1;14(7):2137-44. doi: 10.1158/1078-0432.CCR-07-4530. Clin Cancer Res. 2008. PMID: 18381955

4

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

Danese S, Sans M, Spencer DM, Beck I, Doñate F, Plunkett ML, de la Motte C, Redline R, Shaw DE, Levine AD, Mazar AP, Fiocchi C. Danese S, et al. Among authors: plunkett ml. Gut. 2007 Jun;56(6):855-62. doi: 10.1136/gut.2006.114314. Epub 2006 Dec 14. Gut. 2007. PMID: 17170016 Free PMC article.

5

A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.

Khalili P, Arakelian A, Chen G, Plunkett ML, Beck I, Parry GC, Doñate F, Shaw DE, Mazar AP, Rabbani SA. Khalili P, et al. Among authors: plunkett ml. Mol Cancer Ther. 2006 Sep;5(9):2271-80. doi: 10.1158/1535-7163.MCT-06-0100. Mol Cancer Ther. 2006. PMID: 16985061

6

Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.

Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP. Doñate F, et al. Among authors: plunkett ml. Cancer Res. 2004 Aug 15;64(16):5812-7. doi: 10.1158/0008-5472.CAN-04-0440. Cancer Res. 2004. PMID: 15313924

7

Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.

Juarez JC, Guan X, Shipulina NV, Plunkett ML, Parry GC, Shaw DE, Zhang JC, Rabbani SA, McCrae KR, Mazar AP, Morgan WT, Doñate F. Juarez JC, et al. Among authors: plunkett ml. Cancer Res. 2002 Sep 15;62(18):5344-50. Cancer Res. 2002. PMID: 12235005

8

Pharmacological intervention in antibody mediated disease.

Coutts SM, Plunkett ML, Iverson GM, Barstad PA, Berner CM. Coutts SM, et al. Among authors: plunkett ml. Lupus. 1996 Apr;5(2):158-9. doi: 10.1177/096120339600500214. Lupus. 1996. PMID: 8743132 Review.

9

Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro.

Downs EC, Robertson NE, Riss TL, Plunkett ML. Downs EC, et al. Among authors: plunkett ml. J Cell Physiol. 1992 Aug;152(2):422-9. doi: 10.1002/jcp.1041520225. J Cell Physiol. 1992. PMID: 1379248

10

Epicardial and corneal mineralization in clinically normal severe combined immunodeficiency (SCID) mice.

Meador VP, Tyler RD, Plunkett ML. Meador VP, et al. Among authors: plunkett ml. Vet Pathol. 1992 May;29(3):247-9. doi: 10.1177/030098589202900309. Vet Pathol. 1992. PMID: 1621336 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page